Increased circulating levels of irisin are associated with cardiovascular risk factors in subjects with acromegaly.

Elevated irisin levels in acromegalic subjects were associated with cIMT and EFT, suggesting that irisin is a surrogate marker for cardiovascular risk in acromegalic subjects.